Molecular Partners Ag Stock Price History

MOLN Stock  USD 4.91  0.15  3.15%   
If you're considering investing in Molecular Stock, it is important to understand the factors that can impact its price. As of today, the current price of Molecular Partners stands at 4.91, as last reported on the 9th of October, with the highest price reaching 5.35 and the lowest price hitting 4.75 during the day. Molecular Partners has Sharpe Ratio of -0.0408, which conveys that the firm had a -0.0408% return per unit of risk over the last 3 months. Molecular Partners exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Molecular Partners' Mean Deviation of 4.24, standard deviation of 6.65, and Risk Adjusted Performance of (0.02) to check out the risk estimate we provide.
  
As of the 9th of October 2024, Stock Based Compensation To Revenue is likely to grow to 0.78, while Total Stockholder Equity is likely to drop about 137.3 M. . At this time, Molecular Partners' Price To Sales Ratio is very stable compared to the past year. As of the 9th of October 2024, Price Sales Ratio is likely to grow to 18.48, while Price Earnings Ratio is likely to drop (1.95). Molecular Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.0408

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsMOLN

Estimated Market Risk

 6.74
  actual daily
59
59% of assets are less volatile

Expected Return

 -0.27
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.04
  actual daily
0
Most of other assets perform better
Based on monthly moving average Molecular Partners is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Molecular Partners by adding Molecular Partners to a well-diversified portfolio.
Price Book
0.8978
Enterprise Value Ebitda
1.2347
Price Sales
21.3913
Shares Float
17.3 M
Wall Street Target Price
13.55

Molecular Partners Stock Price History Chart

There are several ways to analyze Molecular Stock price data. The simplest method is using a basic Molecular candlestick price chart, which shows Molecular Partners price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceJuly 31, 20248.58
Lowest PriceOctober 3, 20244.58

Molecular Partners October 9, 2024 Stock Price Synopsis

Various analyses of Molecular Partners' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Molecular Stock. It can be used to describe the percentage change in the price of Molecular Partners from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Molecular Stock.
Molecular Partners Price Rate Of Daily Change 1.03 
Molecular Partners Price Daily Balance Of Power 0.25 
Molecular Partners Price Action Indicator(0.06)

Molecular Partners October 9, 2024 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Molecular Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Molecular Partners intraday prices and daily technical indicators to check the level of noise trading in Molecular Stock and then apply it to test your longer-term investment strategies against Molecular.

Molecular Stock Price History Data

The price series of Molecular Partners for the period between Thu, Jul 11, 2024 and Wed, Oct 9, 2024 has a statistical range of 4.0 with a coefficient of variation of 13.76. The daily prices for the period are spread out with arithmetic mean of 5.93. The median price for the last 90 days is 6.18.
OpenHighLowCloseVolume
10/09/2024
 4.83  5.35  4.75  4.91 
10/08/2024 4.83  5.35  4.75  4.91  2,319 
10/07/2024 4.86  5.32  4.40  4.76  47,698 
10/04/2024 4.60  5.02  4.60  5.02  730.00 
10/03/2024 4.55  4.75  4.53  4.58  10,069 
10/02/2024 4.60  4.77  4.37  4.63  11,952 
10/01/2024 4.75  5.00  4.69  4.79  6,340 
09/30/2024 4.76  5.13  4.76  5.09  11,133 
09/27/2024 5.16  5.37  4.74  5.07  13,379 
09/26/2024 4.86  5.30  4.64  4.69  8,903 
09/25/2024 4.97  4.97  4.62  4.62  4,726 
09/24/2024 4.72  5.02  4.72  5.02  1,953 
09/23/2024 4.60  4.75  4.44  4.73  6,373 
09/20/2024 4.67  4.67  4.67  4.67  137.00 
09/19/2024 4.46  4.67  4.46  4.67  2,341 
09/18/2024 5.03  5.03  4.58  4.84  1,454 
09/17/2024 5.20  5.20  5.08  5.08  1,754 
09/16/2024 5.30  5.30  5.21  5.21  911.00 
09/13/2024 5.27  5.33  5.11  5.22  5,424 
09/12/2024 5.51  5.53  5.51  5.53  889.00 
09/11/2024 5.41  5.55  5.22  5.50  8,521 
09/10/2024 5.34  6.17  5.28  5.61  18,923 
09/09/2024 5.72  5.72  5.20  5.63  5,334 
09/06/2024 6.34  6.97  5.27  5.51  10,278 
09/05/2024 5.85  5.85  5.79  5.79  767.00 
09/04/2024 5.65  5.91  5.65  5.91  2,783 
09/03/2024 5.68  5.74  5.64  5.64  4,990 
08/30/2024 6.29  6.29  5.56  5.68  10,374 
08/29/2024 6.01  6.48  6.01  6.48  1,607 
08/28/2024 6.50  6.50  6.13  6.33  3,712 
08/27/2024 6.35  6.92  6.35  6.92  5,659 
08/26/2024 5.98  6.19  5.98  6.19  4,302 
08/23/2024 6.59  7.41  6.10  6.23  12,704 
08/22/2024 6.52  6.86  6.52  6.70  1,540 
08/21/2024 6.40  6.40  6.33  6.33  1,971 
08/20/2024 6.38  6.38  6.38  6.38  879.00 
08/19/2024 6.21  6.50  6.00  6.50  4,666 
08/16/2024 6.19  6.44  6.19  6.43  1,742 
08/15/2024 6.35  6.37  6.17  6.33  1,869 
08/14/2024 6.41  6.48  6.16  6.38  2,236 
08/13/2024 6.26  6.50  5.94  6.38  6,782 
08/12/2024 6.06  6.15  6.06  6.15  4,076 
08/09/2024 6.17  6.25  5.86  6.04  7,571 
08/08/2024 6.19  6.40  5.84  6.40  6,091 
08/07/2024 6.30  6.41  6.05  6.05  8,454 
08/06/2024 5.93  6.45  5.93  6.17  2,023 
08/05/2024 6.30  6.40  5.75  6.01  5,228 
08/02/2024 8.11  8.11  6.51  6.82  81,914 
08/01/2024 8.21  9.79  7.78  8.00  68,074 
07/31/2024 6.61  12.22  6.50  8.58  444,821 
07/30/2024 6.48  6.50  6.12  6.38  13,308 
07/29/2024 6.36  6.84  6.04  6.72  9,921 
07/26/2024 6.44  6.71  5.81  6.35  25,055 
07/25/2024 6.16  6.53  5.75  5.90  42,559 
07/24/2024 6.45  6.45  6.31  6.31  3,323 
07/23/2024 6.37  6.87  5.70  6.40  30,365 
07/22/2024 6.44  6.67  6.16  6.45  2,126 
07/19/2024 6.58  6.58  6.58  6.58  86.00 
07/18/2024 6.56  6.58  6.56  6.58  543.00 
07/17/2024 6.62  6.62  6.52  6.52  1,302 
07/16/2024 6.59  6.59  6.16  6.35  6,378 

About Molecular Partners Stock history

Molecular Partners investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Molecular is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Molecular Partners will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Molecular Partners stock prices may prove useful in developing a viable investing in Molecular Partners
Last ReportedProjected for Next Year
Common Stock Shares Outstanding32.8 M26 M
Net Income Applicable To Common Shares135.5 M142.3 M

Molecular Partners Quarterly Net Working Capital

154.24 Million

Molecular Partners Stock Technical Analysis

Molecular Partners technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Molecular Partners technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Molecular Partners trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Portfolio Center Now

   

Portfolio Center

All portfolio management and optimization tools to improve performance of your portfolios
All  Next Launch Module

Molecular Partners Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Molecular Partners' price direction in advance. Along with the technical and fundamental analysis of Molecular Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Molecular to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
When determining whether Molecular Partners offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Molecular Partners' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Molecular Partners Ag Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Molecular Partners Ag Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Molecular Partners AG. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Molecular Partners. If investors know Molecular will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Molecular Partners listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.04)
Revenue Per Share
0.239
Quarterly Revenue Growth
2.737
Return On Assets
(0.19)
Return On Equity
(0.32)
The market value of Molecular Partners is measured differently than its book value, which is the value of Molecular that is recorded on the company's balance sheet. Investors also form their own opinion of Molecular Partners' value that differs from its market value or its book value, called intrinsic value, which is Molecular Partners' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Molecular Partners' market value can be influenced by many factors that don't directly affect Molecular Partners' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Molecular Partners' value and its price as these two are different measures arrived at by different means. Investors typically determine if Molecular Partners is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Molecular Partners' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.